Welcome to another installment of Uranimals, a video series featuring urologists and their pets. From an acrobatic cat to an enemy of landscaping, let’s see who some of the top medical professionals are spending time with when they’re not in the clinic!
Sandip M. Prasad, MD, MPhil, details key findings from the phase 3 ENVISION trial, which supported the approval of mitomycin intravesical solution in LG-IR-NMIBC.
According to the authors, these data support the value of PSMA PET/CT in the pre-salvage radiotherapy selection process.
Suzanne B. Merrill, MD, FACS, unpacks key findings from the CREST trial and outlines data of interest from the POTOMAC and PATAPSCO trials, which are…
The ARCHER trial is seeking to determine whether ultra-hypofractionated radiotherapy is non-inferior to hypofractionated radiotherapy in terms of bladder-intact event-free survival.
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, emphasizes a careful, individualized approach to managing bladder and bowel symptoms in women with a history…
Jennifer A. Robles, MD, MPH, outlines 3 key factors that may be preventing more widespread adoption of HoLEP across the US.
The agent is currently being evaluated in a phase 1/2 trial.
Timothy D. McClure outlines his approach to patient selection with focal therapy as well as how NanoKnife fits into that landscape.
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
“Pediatric-type cancer diagnoses in adults are rare, and there are important differences in caring for children with genitourinary malignancies compared with adults,” write the authors.
